Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02281149

Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:

Sponsor: Centre Oscar Lambret

View on ClinicalTrials.gov

Summary

Adjuvant radiotherapy after lumpectomy allows a local long-term control of the order 85 to 95% with a survival rate equivalent to that of the totally mastectomy. The diminution of the local recurrence rate after irradiation post- lumpectomy is also associated to a best global survival than only the surgery. The adjuvant radiotherapy after partially or totally mastectomy for the progressive tumors is a therapeutic standard (Early Breast Cancer Trialists' Collaborative Group 2011). The aim of our trial of routine care is to record our practices under this breast adjuvant radiotherapy.

Official title: Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: Evaluation of the Toxicity and Quality of Life

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2014-11-18

Completion Date

2026-03-31

Last Updated

2026-03-17

Healthy Volunteers

No

Conditions

Locations (2)

Centre Léonard de Vinci

Douai, France

Centre Oscar Lambret

Lille, France